Hippocrat is a decentralized healthcare platform designed to empower individuals by giving them full control over their health data through the use of blockchain and zero-knowledge proof technologies. The platform ensures that health information remains private and secure while being accessible only with user consent, facilitating personalized and efficient medical care.
By utilizing advanced cryptographic methods, Hippocrat enables the secure sharing of sensitive health data without revealing the actual information, fostering trust between patients and healthcare providers. This innovative approach promotes a more patient-centric healthcare model, emphasizing data ownership and privacy.
The HPO ecosystem also supports the integration of health data for research and development purposes, contributing to advancements in global healthcare. Patients can choose to participate in medical studies securely, while researchers gain access to anonymized, high-quality data to drive medical innovation.
Q: What is the primary use of HPO tokens in the Hippocrat ecosystem?
A: HPO tokens are purchased and used by data consumers in the Hippocrat ecosystem to reward data subjects for sharing their data.
Q: What is HPO, and how did it come about?
A: HPO is a rebranded version of the HUM token. The transition to HPO includes a hard fork, scheduled for Q2 2023, following the rebranding.
Q: What is the total circulation of HPO tokens as of March 2023?
A: The total circulation was 913,409,273.38 tokens, of which 11,772,820 were held by the Foundation.
Q: Are there any tokens currently locked up?
A: Yes, 171,325,000 tokens are locked up and will be released according to a pre-determined schedule.
Q: What will be the maximum supply of HPO tokens after the hard fork?
A: The maximum supply will adjust from 1,250,000,000 to 1,084,734,273.38 tokens. No additional supply will be issued beyond this limit.
Q: How will the token utility be managed in the future?
A: The utility of the token may change based on community and DAO decisions to ensure the ecosystem’s best interest. Hippocrat will also comply with the evolving digital asset regulations of major countries.
Q: What is the purpose of the token distribution plan?
A: The plan aims to foster an open ecosystem where various stakeholders can join and contribute through decentralized governance. It also supports the development of necessary open-source tools and the establishment of a DAO for protocol and policy management.
Q: How will tokens be allocated for the DAO and Community Reward Pool?
A: A total of 130,000,000 HPO tokens will be allocated, with a lock-up release schedule as follows:
Q: What is the Initial Ecosystem Contribution Reward allocation?
A: A total of 41,325,000 HPO tokens will be distributed, with the following release schedule:
Q: How will the HUM to HPO hard fork be executed?
A: The hard fork will occur after activating the lockTransfer function of the HUM token. Transfers of HUM between Ethereum accounts will be restricted during this time, as announced through community channels and exchanges. HPO tokens will then be distributed based on a snapshot of HUM addresses and holdings.
Hippocrat is a decentralized healthcare platform designed to empower individuals by giving them full control over their health data through the use of blockchain and zero-knowledge proof technologies. The platform ensures that health information remains private and secure while being accessible only with user consent, facilitating personalized and efficient medical care.
By utilizing advanced cryptographic methods, Hippocrat enables the secure sharing of sensitive health data without revealing the actual information, fostering trust between patients and healthcare providers. This innovative approach promotes a more patient-centric healthcare model, emphasizing data ownership and privacy.
The HPO ecosystem also supports the integration of health data for research and development purposes, contributing to advancements in global healthcare. Patients can choose to participate in medical studies securely, while researchers gain access to anonymized, high-quality data to drive medical innovation.